Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Healthy Extracts (HYEX) Cost of Revenue (2016 - 2025)

Healthy Extracts (HYEX) has 11 years of Cost of Revenue data on record, last reported at $470725.0 in Q3 2025.

  • For Q3 2025, Cost of Revenue rose 230.44% year-over-year to $470725.0; the TTM value through Sep 2025 reached $1.7 million, up 80.26%, while the annual FY2024 figure was $1.2 million, 39.11% up from the prior year.
  • Cost of Revenue reached $470725.0 in Q3 2025 per HYEX's latest filing, up from $375828.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $623248.0 in Q4 2021 and bottomed at $33764.0 in Q2 2021.
  • Average Cost of Revenue over 5 years is $266902.2, with a median of $280428.0 recorded in 2024.
  • Peak YoY movement for Cost of Revenue: tumbled 82.78% in 2021, then soared 447.63% in 2022.
  • A 5-year view of Cost of Revenue shows it stood at $623248.0 in 2021, then fell by 23.44% to $477163.0 in 2022, then plummeted by 78.37% to $103229.0 in 2023, then soared by 245.61% to $356774.0 in 2024, then surged by 31.94% to $470725.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $470725.0 in Q3 2025, $375828.0 in Q2 2025, and $506295.0 in Q1 2025.